Lupin - Quaterly Results

18 May 2022 Evaluate
The revenue zoomed 13.49% to Rs. 28553.90 millions for the quarter ended March 2022 as compared to Rs. 25159.60 millions during the corresponding quarter last year.The Net Loss for the quarter ended March 2022 is Rs. -358.90 millions as compared to Net Profit of Rs. 3163.60 millions of corresponding quarter ended March 2021Operating profit for the quarter ended March 2022 rose to 5171.50 millions as compared to 4911.20 millions of corresponding quarter ended March 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 28553.90 25159.60 13.49 117716.70 110559.30 6.47 117716.70 110559.30 6.47
Other Income 570.30 660.70 -13.68 2169.90 1290.90 68.09 2169.90 1290.90 68.09
PBIDT 5171.50 4911.20 5.30 4261.30 21731.50 -80.39 4261.30 21731.50 -80.39
Interest 245.80 123.10 99.68 734.70 406.20 80.87 734.70 406.20 80.87
PBDT 4925.70 4788.10 2.87 3526.60 21325.30 -83.46 3526.60 21325.30 -83.46
Depreciation 1310.20 1250.10 4.81 5141.90 5028.30 2.26 5141.90 5028.30 2.26
PBT 3615.50 3538.00 2.19 -1615.30 16297.00 -109.91 -1615.30 16297.00 -109.91
TAX 3974.40 374.40 961.54 271.70 3710.80 -92.68 271.70 3710.80 -92.68
Deferred Tax 3419.40 236.70 1344.61 -306.30 82.30 -472.17 -306.30 82.30 -472.17
PAT -358.90 3163.60 -111.34 -1887.00 12586.20 -114.99 -1887.00 12586.20 -114.99
Equity 909.00 907.40 0.18 909.00 907.40 0.18 909.00 907.40 0.18
PBIDTM(%) 18.11 19.52 -7.22 3.62 19.66 -81.58 3.62 19.66 -81.58

Lupin Share Price

2202.70 16.45 (0.75%)
01-Nov-2024 18:52 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1859.00
Dr. Reddys Lab 1258.75
Cipla 1557.50
Lupin 2202.70
Zydus Lifesciences 1001.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.